Literature DB >> 14762700

Has PET become an important clinical tool in paediatric imaging?

Klaus Hahn, Thomas Pfluger.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14762700     DOI： 10.1007/s00259-004-1470-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  82 in total

Review 1.  Positron emission tomography in pediatric neurology.

Authors:  K K Mohan; D C Chugani; H T Chugani
Journal:  Semin Pediatr Neurol       Date:  1999-06       Impact factor: 1.636

2.  PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Authors:  Lale Kostakoglu; Morton Coleman; John P Leonard; Ichiei Kuji; Holly Zoe; Stanley J Goldsmith
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

3.  Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy.

Authors:  H J Won; K H Chang; J E Cheon; H D Kim; D S Lee; M H Han; I O Kim; S K Lee; C K Chung
Journal:  AJNR Am J Neuroradiol       Date:  1999-04       Impact factor: 3.825

4.  Myocardial blood flow and flow reserve after coronary reimplantation in patients after arterial switch and ross operation.

Authors:  M Hauser; F M Bengel; A Kühn; U Sauer; S Zylla; S L Braun; S G Nekolla; R Oberhoffer; R Lange; M Schwaiger; J Hess
Journal:  Circulation       Date:  2001-04-10       Impact factor: 29.690

Review 5.  PET applications in pediatrics.

Authors:  B L Shulkin
Journal:  Q J Nucl Med       Date:  1997-12

6.  Positron emission tomography using [18F] fluorodeoxyglucose and [11C] l-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors.

Authors:  A M Kaplan; M A Lawson; J Spataro; D J Bandy; C T Bonstelle; S D Moss; K H Manwaring; E M Reiman
Journal:  J Child Neurol       Date:  1999-10       Impact factor: 1.987

7.  Brain tumor imaging with PET and 2-[carbon-11]thymidine.

Authors:  T Vander Borght; S Pauwels; L Lambotte; D Labar; S De Maeght; G Stroobandt; C Laterre
Journal:  J Nucl Med       Date:  1994-06       Impact factor: 10.057

8.  Positron emission tomography myocardial perfusion imaging in children with suspected coronary abnormalities.

Authors:  T P Singh; O Muzik; T F Forbes; M F Di Carli
Journal:  Pediatr Cardiol       Date:  2002-09-25       Impact factor: 1.655

9.  Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.

Authors:  J D Lucas; M J O'Doherty; J C Wong; J B Bingham; P H McKee; C D Fletcher; M A Smith
Journal:  J Bone Joint Surg Br       Date:  1998-05

10.  Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Authors:  B L Shulkin; R J Hutchinson; V P Castle; G A Yanik; B Shapiro; J C Sisson
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105
View more
  3 in total

1.  PET/CT in paediatrics: it is time to increase its use!

Authors:  Isabel Roca; Marc Simó; Constantino Sábado; Josep Sanchez de Toledo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-05       Impact factor: 9.236

2.  Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology.

Authors:  J Stauss; C Franzius; T Pfluger; K U Juergens; L Biassoni; J Begent; R Kluge; H Amthauer; T Voelker; L Højgaard; S Barrington; S Hain; T Lynch; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 3.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.